An Australian biotech tech company is the first in the world to develop a potential nanocellular Covid-19 vaccine that’s expected to be more efficient against mutant strains and better suited for patients with compromised immune systems.
via Technology | news.com.au — Australia’s leading news site https://ift.tt/3pduBxo
Aucun commentaire:
Enregistrer un commentaire